top of page
Search

CSInc. updates on CS-1103 at Behavioral Healthcare Symposium organized by CA Hospital Association

  • Clear Scientific
  • Dec 12, 2022
  • 1 min read

Cambridge, MA | December 2022


Shekar Shetty, Clear Scientific Inc.’s CEO, gave an update on our first- in-class therapeutic agent CS-1103 to treat methamphetamine overdose at the Behavioral Health Care Symposium entitled “Hope for treating Methamphetamine Use Disorder”, organized by the California Hospital Association at Riverside CA. CS-1103 is designed to lower the level of methamphetamine in the human body and rapidly resolve its toxic effects. Remove the Cause Remove the EffectTM is the hallmark of Clear Scientific’s therapeutic approach.

 
 
 

Recent Posts

See All

Comentários


CSLogo_F-clear.png

737 Concord Avenue

Cambridge, MA 02138

(617) 621-8500

casestudy-linkedin-logo-grey.png
Contact Us

Thanks for submitting!

© 2022 Clear Scientific, Inc.

bottom of page